New: Instantly spot drawdowns, dips, insider moves, and breakout themes across Maps and Screener.

TELA Bio, Inc.

Contributing Author

Recent Articles by TELA Bio, Inc.

Jan-23	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA GlobeNewswire
Dec-12	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA GlobeNewswire
Nov-19	TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference TELA -8.47% GlobeNewswire
Nov-17	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA +14.08% GlobeNewswire
Nov-13	TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants TELA -9.97% TELA GlobeNewswire
Nov-13	TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility TELA -9.97% TELA GlobeNewswire
Nov-04	TELA Bio to Announce Third Quarter 2025 Financial Results TELA -5.84% GlobeNewswire
Nov-03	TELA Bio Appoints William Plovanic to Board of Directors TELA +11.38% GlobeNewswire
Oct-09	TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran TELA GlobeNewswire
Aug-11	TELA Bio Reports Second Quarter 2025 Financial Results TELA -13.98% TELA +8.14% GlobeNewswire
Aug-08	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA GlobeNewswire
Jul-23	TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference TELA GlobeNewswire
Jul-21	TELA Bio to Announce Second Quarter 2025 Financial Results TELA -7.04% GlobeNewswire
Jun-06	TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) TELA GlobeNewswire
Jun-03	TELA Bio Announces European Commercial Launch of OviTex Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair TELA +19.75% TELA +10.56% GlobeNewswire
Jun-02	TELA Bio Appoints Jeffrey Blizard as President TELA GlobeNewswire
May-22	TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference TELA GlobeNewswire
May-09	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TELA +9.04% TELA -6.48% GlobeNewswire
May-08	TELA Bio Reports First Quarter 2025 Financial Results TELA GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.